跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72,654 条关于
“leucine-rich repeat kinase 2”
全部
72,654
临床试验
47,972
药物
7,745
机构
1,432
资讯
15,505
去年
Halia Therapeutics Presents LRRK2 Inhibitor HT-4253 for Neurodegenerative Diseases at BIO Investor Forum
去年
Denali Therapeutics Initiates Phase 2a Trial of BIIB122 for LRRK2-Associated Parkinson's Disease
2年前
Parkinson's Drug DNL-151 Phase III Trial Terminated; Lerodalcibep Shows Promise in Hypercholesterolemia
去年
Vanqua Bio's VQ-101 Shows Promise in Parkinson's Disease with Phase Ib Trial Initiation
去年
Advancements in Parkinson's Disease Therapy: A Review of Current Strategies and Future Research Priorities
5个月前
Biognosys Partners with Michael J. Fox Foundation to Develop Critical LRRK2 Biomarker Assays for Parkinson's Disease
去年
Arvinas' ARV-102 Shows Promising Brain Penetration and LRRK2 Reduction in First-in-Human Parkinson's Trial
去年
Montara Therapeutics Receives $3.3M Grant from Michael J. Fox Foundation to Develop Brain-Selective LRRK2 Inhibitor for Parkinson's
去年
Brenig Therapeutics Appoints New Leadership and Expands Parkinson's Disease Pipeline with NLRP3 Inhibitor Acquisition
3个月前
Genetics of Parkinson Disease: Paradigm Shifts and Future Prospects
第 1 页,共 1551 页
上一页
下一页